SCI Abstract

search
+
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists
In men with prolactinoma treated with dopamine agonists (DA), the extent, timeline, and predictive factors of gonadotropic...
Natural history of untreated microprolactinomas
Natural history of untreated microprolactinomas
Cite this articleSadek, M., Clarke, D.B. & Imran, S.A. Natural history of untreated microprolactinomas. ...
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism
Lipoatrophy is rare adverse event (AE) in daily recombinant human growth hormone (rhGH). Data on lipoatrophy in newly deve...
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan
To elucidate the long-term efficacy and safety of growth hormone replacement therapy (GHRT) in Japanese patients with adul...
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis
Acromegaly is a rare chronic endocrine disorder associated with significant comorbidities. Many patients fail to achieve b...
Hypophysitis in COVID-19: a systematic review
Hypophysitis in COVID-19: a systematic review
This systematic review aims to collect and examine recent research findings regarding hypophysitis in COVID-19 patients. W...
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management
Following the description of an illustrative case of a 70-year-old female patient with longstanding active acromegaly and ...
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
A series of consensus guidelines on medical treatment of acromegaly have been produced in the last two decades. However, l...
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study
Cardiac abnormalities are common in patients with acromegaly, contributing to the increased morbidity and mortality. Cardi...
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery
Copeptin efficiently predicts post-neurosurgical central diabetes insipidus (CDI) in patients with hypothalamic-pituitary ...
Pituitary apoplexy in cushing’s disease: a single center study and systematic literature review
Pituitary apoplexy in cushing’s disease: a single center study and systematic literature review
Pituitary apoplexy (PA) in Cushing’s disease (CD) is rare with data limited to case reports/series. We retrospective...
The conundrum of differentiating Cushing’s syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis
The conundrum of differentiating Cushing’s syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis
Once hypercortisolemia is confirmed, differential diagnosis between Cushing’s syndrome (CS) due to neoplastic endoge...
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification
For asymptomatic non-functioning pituitary adenomas (NFPAs), conservative approaches such as observation are preferred. Ho...
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
We previously showed the clinical characteristics of acromegaly with a paradoxical growth hormone (GH) response to oral gl...
Pituitary apoplexy: a systematic review of non-gestational risk factors
Pituitary apoplexy: a systematic review of non-gestational risk factors
Pregnancy is a known risk factor for Pituitary Apoplexy (PA) but there is a lack of consistency in the literature regardin...
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
To investigate the impact of pituitary surgery on glucose metabolism and to identify predictors of remission of diabetes a...
Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model
Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model
Growth hormone (GH) is a central regulator of β-cell proliferation, insulin secretion and sensitivity. Aim of this st...
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients
The impact of GH/IGF-1 levels on skeletal muscle in acromegaly is still controversial. Temporal (TMT) and masseter muscle ...
Pituitary surgery and COVID
Pituitary surgery and COVID
An effect of the COVID-19 pandemic was the disruption of healthcare systems, especially surgical services provided to the ...
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders
Successful treatment outcomes of adults with hypothalamic-pituitary disorders necessitate the adoption of intricate self-m...
Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent
Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent
Silent corticotroph tumors (siACTH) represent a rare entity of pituitary tumors (PT), usually more aggressive than other P...
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease
Isolated adrenocorticotropic hormone deficiency (IAD) is considered to be a rare disease. Due to the nonspecific clinical ...
Pituitary apoplexy score, toward standardized decision-making: a descriptive study
Pituitary apoplexy score, toward standardized decision-making: a descriptive study
Pituitary apoplexy (PA), a rare and life-threatening complication of pituitary adenomas, prompts urgent glucocorticoid adm...
Correction: incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies
Correction: incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies
Cite this articleGalbiati, F., Venugopal, S., Abou-Al-Shaar, H. et al. Correction: incidence of postoperative hyponatremia...
Different patient versus provider perspectives on living with Cushing’s disease
Different patient versus provider perspectives on living with Cushing’s disease
Patients with Cushing’s disease (CD) face challenges living with and receiving appropriate care for this rare, chron...
Elevated risk of recurrence and retreatment for silent pituitary adenomas
Elevated risk of recurrence and retreatment for silent pituitary adenomas
Pituitary adenomas are the most common tumor of the pituitary gland and comprise nearly 15% of all intracranial masses. Th...
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test
Insulin sensitivity (Si) and its role in glucose intolerance of acromegaly has been extensively evaluated. However, data o...
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2
The recent WHO 2022 Classification of pituitary tumours identified a novel group of ‘plurihormonal tumours without d...
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center
Prolactin (PRL)-secreting tumours are associated with infertility and can be reverted by dopamine agonist (DA) therapy. Th...
The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly
The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly
The aim of this study was to investigate the prevalence of simple renal cysts (SRCs) and kidney stone disease (KSD) togeth...
Load More
format_indent_increase